Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Astellas Pharma Inc.

    OTC: ALPMY · Real-Time Price · USD
    11.33
    0.15 (1.34%)
    At close: Aug 15, 2025, 3:58 PM
    11.30
    -0.26%
    After-hours: Aug 15, 2025, 03:58 PM EDT

    Astellas Pharma Income Statement

    Financials in JPY. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
    Revenue
    		 1,912.3B 1,867.6B 1,772.2B 1,701.8B 1,603.7B 1,543.3B 1,523.6B 1,511.8B 1,518.6B 1,468.2B 1,406.7B 1,351.8B 1,296.2B 1,300.9B 1,285.7B 1,268.7B 1,249.5B 1,253.2B 1,265.9B 1,273.7B
    Cost of Revenue
    		 349.21B 378.22B 388.04B 404.43B 391.3B 356.97B 332.26B 305.19B 326.79B 322.2B 315.8B 312.71B 281.29B 279.14B 270.1B 261.07B 252.53B 242.83B 257.42B 265.88B
    Gross Profit
    		 1,563.1B 1,489.4B 1,384.1B 1,297.4B 1,212.4B 1,186.4B 1,191.3B 1,206.6B 1,191.8B 1,146B 1,090.9B 1,039.1B 1,014.9B 1,021.8B 1,015.6B 1,007.6B 997B 1,010.4B 1,008.4B 1,007.8B
    Operating Income
    		 63.81B 38.02B 193.92B 167.19B 178.07B 193.69B 242.63B 294.86B 285.43B 258.22B 238.47B 212.27B 220.02B 240.77B 244.47B 208.31B 206.62B 187.38B 191.02B 250.51B
    Interest Income
    		 162M 4.29B 5.47B 7.84B 11.45B 9.77B 9.77B 10.96B 8.11B 9.51B 8.75B 5.62B 6.15B 7.41B 10.05B 12.69B 11.61B 8.02B 7.45B 4.44B
    Pretax Income
    		 31.24B -75.27B 60.62B 28.32B 23.99B 22.18B 64.81B 145.94B 131.1B 169.89B 186.32B 152.19B 156.4B 145.72B 144.27B 119.88B 144.58B 170.39B 172.86B 229.06B
    Net Income
    		 50.75B -57.43B 54.75B 17.38B 12.9B 58M 33.95B 107.03B 98.72B 136.43B 148.91B 118.21B 124.08B 120.17B 119.36B 100.86B 120.59B 138.31B 139.72B 187.31B
    Selling & General & Admin
    		 843.03B 824.87B 799.06B 778.8B 740.11B 706.26B 669.78B 645.06B 630.27B 613.4B 586.29B 565.13B 548.84B 547.69B 532.69B 520.65B 504.32B 508.76B 515.36B 502.6B
    Research & Development
    		 327.65B 329.27B 324.57B 316.42B 294.19B 286.41B 278.9B 266.71B 276.13B 274.41B 266.13B 261.7B 246.01B 233.32B 231.85B 225.51B 224.49B 233.27B 230.93B 227.98B
    Other Expenses
    		 293.65B 262.28B 31.6B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 1,502B 1,454.1B 1,192.9B 1,132.9B 1,034.3B 992.67B 948.68B 911.77B 906.4B 887.81B 852.42B 826.83B 794.85B 781.01B 771.15B 799.56B 790.64B 843.24B 838.43B 778.73B
    Interest Expense
    		 324M 4.51B 7.34B 9.61B 12.01B 9.89B 9.86B 9.1B 8.78B 7.38B 5.88B 5.63B 4.95B 4.86B 4.08B 3.1B 2.34B 2.45B 2.28B 2.12B
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 1,851.2B 1,832.3B 1,580.9B 1,537.3B 1,425.6B 1,349.6B 1,280.9B 1,217B 1,233.2B 1,210B 1,168.2B 1,139.5B 1,076.1B 1,060.1B 1,041.2B 1,060.6B 1,043.2B 1,086.1B 1,095.8B 1,044.6B
    Income Tax Expense
    		 -19.51B -20.55B 2.95B 7.09B 7.92B 21.56B 30.11B 40.5B 33.65B 33.29B 39.37B 34.52B 32.8B 28.33B 25.96B 20.05B 24.73B 32.09B 33.14B 41.75B
    Shares Outstanding (Basic)
    		 1.82B 1.79B 1.8B 1.8B 1.79B 1.79B 1.79B 1.79B 1.81B 1.82B 1.82B 1.83B 1.84B 1.85B 1.85B 1.85B 1.86B 1.86B 1.86B 1.86B
    Shares Outstanding (Diluted)
    		 1.82B 1.79B 1.8B 1.8B 1.79B 1.8B 1.79B 1.8B 1.81B 1.82B 1.82B 1.83B 1.84B 1.85B 1.85B 1.85B 1.86B 1.86B 1.86B 1.86B
    EPS (Basic)
    		 28.26 -32.13 30.53 9.66 7.18 0.25 18.72 58.83 53.97 74.89 81.19 63.98 66.94 64.87 64.34 54.32 64.88 74.42 74.87 99.90
    EPS (Diluted)
    		 27.53 -32.22 30.41 9.63 7.11 0.18 18.67 58.76 53.93 74.85 81.14 63.93 66.89 64.82 64.31 54.31 64.88 74.42 74.87 99.90
    EBITDA
    		 419.48B 321.86B 262.93B 221.45B 190.68B 163.72B 182.15B 248.75B 246.88B 280.91B 296.49B 256.77B 241.52B 295.73B 285.33B 256.13B 279.27B 238.79B 241.43B 297B
    EBIT
    		 222.02B 123.44B 68.69B 38.26B 32.84B 31.5B 73.92B 156.63B 141.14B 177.1B 194.16B 158.36B 161.84B 153.36B 149.4B 124.01B 147.66B 172.84B 175.14B 231.69B
    Depreciation & Amortization
    		 199.13B 200.09B 195.91B 184.86B 157.84B 132.21B 108.23B 92.11B 105.74B 103.8B 102.33B 98.41B 79.68B 77.16B 73.79B 72.8B 72.65B 72.19B 71.19B 67.38B

    Add to Watchlist